Triple
T363283
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Genentech |
E7901
|
entity |
| Predicate | notableProduct |
P1448
|
FINISHED |
| Object |
Herceptin
Herceptin is a targeted monoclonal antibody drug used primarily to treat HER2-positive breast cancer by blocking the HER2 receptor on cancer cells.
|
E46088
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69a2e7e880008190a6ad7e06e5d03007 |
elicitation | completed |
| NER | batch_69a2ebd1016481909b8ba3b047a47145 |
ner | completed |
| NED1 | batch_69a3e86533a481909bab5f0b52114c6a |
ned_source_triple | completed |
| NED2 | batch_69a3ea45c86c8190a6c215430601ad15 |
ned_description | completed |
| NEDg | batch_69a3e99fd210819099e83cd183a4daa7 |
nedg | completed |
Created at: Feb. 28, 2026, 1:08 p.m.